Scarica l'app Stockscreener
21.84
2.72%
-0.61
Dopo l'orario di chiusura:
21.95
0.11
+0.50%
Precedente Chiudi:
$22.45
Aprire:
$21.64
Volume 24 ore:
1.60M
Relative Volume:
1.01
Capitalizzazione di mercato:
$2.47B
Reddito:
$6.94M
Utile/perdita netta:
$-212.39M
Rapporto P/E:
-8.9951
EPS:
-2.428
Flusso di cassa netto:
$-200.60M
1 W Prestazione:
+7.01%
1M Prestazione:
-1.67%
6M Prestazione:
+90.41%
1 anno Prestazione:
+225.48%
Intervallo 1D:
$21.41
$22.62
Intervallo di 1 settimana:
$19.16
$23.14
Portata 52W:
$5.1501
$27.65
Immunome Inc Stock (IMNM) Company Profile
Nome
Immunome Inc
Settore
Industria
Telefono
610-321-3700
Indirizzo
18702 N. CREEK PARKWAY, BOTHELL
Compare IMNM vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
21.84 | 2.47B | 6.94M | -212.39M | -200.60M | -2.428 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Immunome Inc Stock (IMNM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-12 | Iniziato | H.C. Wainwright | Buy |
| 2025-12-01 | Iniziato | Truist | Buy |
| 2025-09-22 | Iniziato | Goldman | Buy |
| 2025-09-05 | Iniziato | Craig Hallum | Buy |
| 2025-04-02 | Iniziato | Lake Street | Buy |
| 2024-11-08 | Iniziato | Stephens | Overweight |
| 2024-05-31 | Iniziato | Piper Sandler | Overweight |
| 2024-04-30 | Iniziato | JP Morgan | Overweight |
| 2024-04-15 | Iniziato | Guggenheim | Buy |
| 2024-01-29 | Iniziato | Leerink Partners | Outperform |
| 2023-12-19 | Iniziato | Wedbush | Outperform |
| 2021-10-29 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Immunome Inc Borsa (IMNM) Ultime notizie
Immunome CSO Sells Shares: Transaction Details & Company SnapshotNews and Statistics - IndexBox
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More - AOL.com
Insider Sell: What is the long term forecast for Immunome Inc stockDividend Hike & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Immunome's Chief Scientist Trimmed His Stake. A Planned FDA Submission Tells You More - The Motley Fool
A Look At Immunome (IMNM) Valuation After Oncology Progress EPS Upgrades And CEO Insider Buying - Sahm
Immunome, Inc. (IMNM) stock price, news, quote and history - Yahoo Finance Singapore
Immunome Inc (IMNM) CSO Higgins sells $204,238 in stock By Investing.com - Investing.com Canada
Immunome CFO Rosett sells $1.4m in shares By Investing.com - Investing.com Canada
Immunome Inc (IMNM) CSO Higgins sells $204,238 in stock - Investing.com
Immunome CFO Rosett sells $1.4m in shares - Investing.com
Insider Selling: Immunome (NASDAQ:IMNM) Insider Sells 9,438 Shares of Stock - MarketBeat
Insider Selling: Immunome (NASDAQ:IMNM) CFO Sells $1,424,800.00 in Stock - MarketBeat
Immunome (IMNM) CSO pre-planned 9,438-share sale under Rule 10b5-1 - Stock Titan
Immunome (IMNM) CFO exercises 71,561 options and sells 65,000 shares - Stock Titan
IMNM (NASDAQ: IMNM) Form 144/A: 65,000 shares proposed sale via Fidelity - Stock Titan
Tema Etfs LLC Has $2.19 Million Position in Immunome, Inc. $IMNM - MarketBeat
SG Americas Securities LLC Raises Stock Position in Immunome, Inc. $IMNM - MarketBeat
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Immunome reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Proposed common-share sale reported by IMNM (NASDAQ: IMNM) - Stock Titan
IMNM (NASDAQ: IMNM) files Form 144 for proposed stock sales - Stock Titan
Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last? - qz.com
Immunome (NASDAQ: IMNM) CSO gifts 6,291 shares, retains 31,438 - Stock Titan
Immunome (IMNM) Surges by 13.3%: Can This Momentum Continue? - Bitget
Tuesday’s insider activity: CEO doubles down on biotech stock By Investing.com - Investing.com South Africa
Volume Summary: Can Immunome Inc be the next market leader2026 Trade Ideas & Growth Focused Stock Pick Reports - baoquankhu1.vn
Goldman Sachs Initiates Coverage of Immunome (IMNM) with Buy Recommendation - MSN
Immunome (NASDAQ:IMNM) Stock Price Up 9.4%What's Next? - MarketBeat
Insider Buying: Clay Siegall Acquires Shares of Immunome Inc (IM - GuruFocus
Immunome Insider Bought Shares Worth $500,602, According to a Recent SEC Filing - MarketScreener
Immunome CEO Clay Siegall buys $500k in shares By Investing.com - Investing.com South Africa
Immunome CEO Clay Siegall buys $500k in shares - Investing.com
Immunome (IMNM) CEO adds 25,450 shares in $19.67 stock purchase - Stock Titan
Immunome Inc Stock: Clinical-Stage Biotech Targeting Cancer and Infectious Diseases with Innovative - AD HOC NEWS
Recap Report: What is the long term forecast for Immunome Inc stockWeekly Investment Summary & Long-Term Safe Investment Ideas - baoquankhu1.vn
Vanguard disaggregates holdings; IMNM shows 0 shares after realignment (IMNM) - Stock Titan
Don't Ignore The Insider Selling In Immunome - simplywall.st
Immunome Insider Sold Shares Worth $1,335,626, According to a Recent SEC Filing - marketscreener.com
Director Philip Wagenheim Sells 65,000 Shares of Immunome Inc (I - GuruFocus
Immunome Inc: director Wagenheim sells $1.3m in shares By Investing.com - Investing.com South Africa
Immunome (NASDAQ:IMNM) Director Philip Wagenheim Sells 28,200 Shares - MarketBeat
Philip Wagenheim Sells 36,800 Shares of Immunome (NASDAQ:IMNM) Stock - marketbeat.com
Immunome Inc: director Wagenheim sells $1.3m in shares - Investing.com
Immunome (IMNM) director sells 65,000 shares in open market - Stock Titan
IMNM PE Ratio & Valuation, Is IMNM Overvalued - intellectia.ai
Immunome Inc stock surges on breakthrough oncology data, drawing DACH biotech investor interest - AD HOC NEWS
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Form 144 Immunome Inc. For: 20 March By Investing.com - Investing.com Australia
Smart Money: Is Immunome Inc forming a breakout patternQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Form 144 Immunome Inc. For: 20 March - Investing.com
Immunome Inc Azioni (IMNM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):